Works by Goldman, Stewart

Results: 110
    1

    A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 149, n. 3, p. 437, doi. 10.1007/s11060-020-03627-0
    By:
    • Hipp, Sean J.;
    • Goldman, Stewart;
    • Kaushal, Aradhana;
    • Krauze, Andra;
    • Citrin, Deborah;
    • Glod, John;
    • Walker, Kim;
    • Shih, Joanna H.;
    • Sethumadhavan, Hema;
    • O'Neill, Keith;
    • Garvin, James H.;
    • Glade-Bender, Julia;
    • Karajannis, Matthias A.;
    • Atlas, Mark P.;
    • Odabas, Arman;
    • Rodgers, Louis T.;
    • Peer, Cody J.;
    • Savage, Jason;
    • Camphausen, Kevin A.;
    • Packer, Roger J.
    Publication type:
    Article
    2
    3

    A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 443, doi. 10.1007/s11060-016-2189-7
    By:
    • Salloum, Ralph;
    • Hummel, Trent;
    • Kumar, Shiva;
    • Dorris, Kathleen;
    • Li, Shaoyu;
    • Lin, Tong;
    • Daryani, Vinay;
    • Stewart, Clinton;
    • Miles, Lili;
    • Poussaint, Tina;
    • Stevenson, Charles;
    • Goldman, Stewart;
    • Dhall, Girish;
    • Packer, Roger;
    • Fisher, Paul;
    • Pollack, Ian;
    • Fouladi, Maryam;
    • Boyett, James;
    • Drissi, Rachid
    Publication type:
    Article
    4

    A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 127, n. 1, p. 53, doi. 10.1007/s11060-015-2008-6
    By:
    • Hummel, Trent;
    • Salloum, Ralph;
    • Drissi, Rachid;
    • Kumar, Shiva;
    • Sobo, Matthew;
    • Goldman, Stewart;
    • Pai, Ahna;
    • Leach, James;
    • Lane, Adam;
    • Pruitt, David;
    • Sutton, Mary;
    • Chow, Lionel;
    • Grimme, Laurie;
    • Doughman, Renee;
    • Backus, Lori;
    • Miles, Lili;
    • Stevenson, Charles;
    • Fouladi, Maryam;
    • DeWire, Mariko
    Publication type:
    Article
    5

    An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN).

    Published in:
    Journal of Neuro-Oncology, 2015, v. 123, n. 1, p. 85, doi. 10.1007/s11060-015-1764-7
    By:
    • DeWire, Mariko;
    • Fouladi, Maryam;
    • Turner, David;
    • Wetmore, Cynthia;
    • Hawkins, Cynthia;
    • Jacobs, Carmen;
    • Yuan, Ying;
    • Liu, Diane;
    • Goldman, Stewart;
    • Fisher, Paul;
    • Rytting, Michael;
    • Bouffet, Eric;
    • Khakoo, Yasmin;
    • Hwang, Eugene;
    • Foreman, Nicholas;
    • Stewart, Clinton;
    • Gilbert, Mark;
    • Gilbertson, Richard;
    • Gajjar, Amar
    Publication type:
    Article
    6
    7
    8

    Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 121, n. 1, p. 217, doi. 10.1007/s11060-014-1665-1
    By:
    • Packer, Roger;
    • Rood, Brian;
    • Turner, David;
    • Stewart, Clinton;
    • Fisher, Michael;
    • Smith, Christopher;
    • Young-Pouissant, Tina;
    • Goldman, Stewart;
    • Lulla, Rishi;
    • Banerjee, Anu;
    • Pollack, Ian;
    • Kun, Larry;
    • Onar-Thomas, Arzu;
    • Wu, Shengjie;
    • Boyett, James;
    • Fouladi, Maryam
    Publication type:
    Article
    9
    10
    11
    12

    Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001).

    Published in:
    Journal of Neuro-Oncology, 2012, v. 109, n. 3, p. 565, doi. 10.1007/s11060-012-0929-x
    By:
    • Blaney, Susan;
    • Kocak, Mehmet;
    • Gajjar, Amar;
    • Chintagumpala, Murali;
    • Merchant, Thomas;
    • Kieran, Mark;
    • Pollack, Ian;
    • Gururangan, Sri;
    • Geyer, Russ;
    • Phillips, Peter;
    • McLendon, Roger;
    • Packer, Roger;
    • Goldman, Stewart;
    • Banerjee, Anu;
    • Heideman, Richard;
    • Boyett, James;
    • Kun, Larry
    Publication type:
    Article
    13

    A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.

    Published in:
    Journal of Neuro-Oncology, 2012, v. 106, n. 3, p. 643, doi. 10.1007/s11060-011-0709-z
    By:
    • Warren, Katherine;
    • Gururangan, Sri;
    • Geyer, J.;
    • McLendon, Roger;
    • Poussaint, Tina;
    • Wallace, Dana;
    • Balis, Frank;
    • Berg, Stacey;
    • Packer, Roger;
    • Goldman, Stewart;
    • Minturn, Jane;
    • Pollack, Ian;
    • Boyett, James;
    • Kun, Larry
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.

    Published in:
    Sarcoma, 2017, p. 1, doi. 10.1155/2017/8685638
    By:
    • Higham, Christine S.;
    • Steinberg, Seth M.;
    • Dombi, Eva;
    • Perry, Arie;
    • Helman, Lee J.;
    • Schuetze, Scott M.;
    • Ludwig, Joseph A.;
    • Staddon, Arthur;
    • Milhem, Mohammed M.;
    • Rushing, Daniel;
    • Jones, Robin L.;
    • Livingston, Michael;
    • Goldman, Stewart;
    • Moertel, Christopher;
    • Wagner, Lars;
    • Janhofer, David;
    • Annunziata, Christina M.;
    • Reinke, Denise;
    • Long, Lauren;
    • Viskochil, David
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System.

    Published in:
    Brain Pathology, 2013, v. 23, n. 5, p. 584, doi. 10.1111/bpa.12050
    By:
    • Raghunathan, Aditya;
    • Wani, Khalida;
    • Armstrong, Terri S.;
    • Vera‐Bolanos, Elizabeth;
    • Fouladi, Maryam;
    • Gilbertson, Richard;
    • Gajjar, Amar;
    • Goldman, Stewart;
    • Lehman, Norman L.;
    • Metellus, Phillipe;
    • Mikkelsen, Tom;
    • Necesito‐Reyes, Mary Jo T.;
    • Omuro, Antonio;
    • Packer, Roger J.;
    • Partap, Sonia;
    • Pollack, Ian F.;
    • Prados, Michael D.;
    • Robins, H. Ian;
    • Soffietti, Riccardo;
    • Wu, Jing
    Publication type:
    Article
    26

    A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042).

    Published in:
    Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28879
    By:
    • Van Mater, David;
    • Gururangan, Sridharan;
    • Becher, Oren;
    • Campagne, Olivia;
    • Leary, Sarah;
    • Phillips, Joanna J.;
    • Huang, Jie;
    • Lin, Tong;
    • Poussaint, Tina Young;
    • Goldman, Stewart;
    • Baxter, Patricia;
    • Dhall, Girish;
    • Robinson, Giles;
    • DeWire‐Schottmiller, Mariko;
    • Hwang, Eugene I.;
    • Stewart, Clinton F.;
    • Onar‐Thomas, Arzu;
    • Dunkel, Ira J.;
    • Fouladi, Maryam
    Publication type:
    Article
    27
    28
    29
    30
    31

    Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.

    Published in:
    Pediatric Blood & Cancer, 2014, v. 61, n. 9, p. 1598, doi. 10.1002/pbc.25041
    By:
    • Widemann, Brigitte C.;
    • Babovic‐Vuksanovic, Dusica;
    • Dombi, Eva;
    • Wolters, Pamela L.;
    • Goldman, Stewart;
    • Martin, Staci;
    • Goodwin, Anne;
    • Goodspeed, Wendy;
    • Kieran, Mark W.;
    • Cohen, Bruce;
    • Blaney, Susan M.;
    • King, Allison;
    • Solomon, Jeffrey;
    • Patronas, Nicholas;
    • Balis, Frank M.;
    • Fox, Elizabeth;
    • Steinberg, Seth M.;
    • Packer, Roger J
    Publication type:
    Article
    32

    A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.

    Published in:
    Pediatric Blood & Cancer, 2014, v. 61, n. 4, p. 636, doi. 10.1002/pbc.24794
    By:
    • Robison, Nathan J.;
    • Campigotto, Federico;
    • Chi, Susan N.;
    • Manley, Peter E.;
    • Turner, Christopher D.;
    • Zimmerman, Mary Ann;
    • Chordas, Christine A.;
    • Werger, Annette M.;
    • Allen, Jeffrey C.;
    • Goldman, Stewart;
    • Rubin, Joshua B.;
    • Isakoff, Michael S.;
    • Pan, Wilbur J.;
    • Khatib, Ziad A.;
    • Comito, Melanie A.;
    • Bendel, Anne E.;
    • Pietrantonio, Jay B.;
    • Kondrat, Laura;
    • Hubbs, Shannon M.;
    • Neuberg, Donna S.
    Publication type:
    Article
    33

    Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology (RAPNO) working group.

    Published in:
    Pediatric Blood & Cancer, 2013, v. 60, n. 9, p. 1397, doi. 10.1002/pbc.24562
    By:
    • Warren, Katherine E.;
    • Poussaint, Tina Y.;
    • Vezina, Gilbert;
    • Hargrave, Darren;
    • Packer, Roger J.;
    • Goldman, Stewart;
    • Wen, Patrick Y.;
    • Pollack, Ian F.;
    • Zurakowski, David;
    • Kun, Larry E.;
    • Prados, Michael D.;
    • Rutkowski, Stefan;
    • Kieran, Mark W.
    Publication type:
    Article
    34
    35
    36

    Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.

    Published in:
    2020
    By:
    • Mueller, Sabine;
    • Taitt, Jared M.;
    • Villanueva-Meyer, Javier E.;
    • Bonner, Erin R.;
    • Nejo, Takahide;
    • Lulla, Rishi R.;
    • Goldman, Stewart;
    • Banerjee, Anu;
    • Chi, Susan N.;
    • Whipple, Nicholas S.;
    • Crawford, John R.;
    • Gauvain, Karen;
    • Nazemi, Kellie J.;
    • Watchmaker, Payal B.;
    • Almeida, Neil D.;
    • Okada, Kaori;
    • Salazar, Andres M.;
    • Gilbert, Ryan D.;
    • Nazarian, Javad;
    • Molinaro, Annette M.
    Publication type:
    journal article
    37
    38

    Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.

    Published in:
    Nature Genetics, 2014, v. 46, n. 5, p. 462, doi. 10.1038/ng.2950
    By:
    • Fontebasso, Adam M;
    • Papillon-Cavanagh, Simon;
    • Schwartzentruber, Jeremy;
    • Nikbakht, Hamid;
    • Gerges, Noha;
    • Fiset, Pierre-Olivier;
    • Bechet, Denise;
    • Faury, Damien;
    • De Jay, Nicolas;
    • Ramkissoon, Lori A;
    • Corcoran, Aoife;
    • Jones, David T W;
    • Sturm, Dominik;
    • Johann, Pascal;
    • Tomita, Tadanori;
    • Goldman, Stewart;
    • Nagib, Mahmoud;
    • Bendel, Anne;
    • Goumnerova, Liliana;
    • Bowers, Daniel C
    Publication type:
    Article
    39

    A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2364, doi. 10.1093/neuonc/noae142
    By:
    • Lim-Fat, Mary Jane;
    • Cotter, Jennifer A;
    • Touat, Mehdi;
    • Vogelzang, Jayne;
    • Sousa, Cecilia;
    • Pisano, Will;
    • Geduldig, Jack;
    • Bhave, Varun;
    • Driver, Joseph;
    • Kao, Pei-Chi;
    • McGovern, Alana;
    • Ma, Clement;
    • Margol, Ashley S;
    • Cole, Kristina;
    • Smith, Amy;
    • Goldman, Stewart;
    • Kaneva, Kristiyana;
    • Truong, AiLien;
    • Nazemi, Kellie J;
    • Wood, Matthew D
    Publication type:
    Article
    40

    Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 199, doi. 10.1093/neuonc/noac132
    By:
    • Yeo, Kee Kiat;
    • Alexandrescu, Sanda;
    • Cotter, Jennifer A;
    • Vogelzang, Jayne;
    • Bhave, Varun;
    • Li, Marilyn M;
    • Ji, Jianling;
    • Benhamida, Jamal K;
    • Rosenblum, Marc K;
    • Bale, Tejus A;
    • Bouvier, Nancy;
    • Kaneva, Kristiyana;
    • Rosenberg, Tom;
    • Lim-Fat, Mary Jane;
    • Ghosh, Hia;
    • Martinez, Migdalia;
    • Aguilera, Dolly;
    • Smith, Amy;
    • Goldman, Stewart;
    • Diamond, Eli L
    Publication type:
    Article
    41

    Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 12, p. 2190, doi. 10.1093/neuonc/noac123
    By:
    • Bartlett, Allison L;
    • Lane, Adam;
    • Chaney, Brooklyn;
    • Escorza, Nancy Yanez;
    • Black, Katie;
    • Cochrane, Anne;
    • Minturn, Jane;
    • Bartels, Ute;
    • Warren, Kathy;
    • Hansford, Jordan;
    • Ziegler, David;
    • Diez, Blanca;
    • Goldman, Stewart;
    • Packer, Roger;
    • Kieran, Mark;
    • DeWire-Schottmiller, Mariko;
    • Erker, Craig;
    • Monje-Deisseroth, Michelle;
    • Wagner, Lars;
    • Koschmann, Carl
    Publication type:
    Article
    42
    43

    Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 7, p. 1178, doi. 10.1093/neuonc/noab293
    By:
    • Leary, Sarah E S;
    • Kilburn, Lindsay;
    • Geyer, J Russell;
    • Kocak, Mehmet;
    • Huang, Jie;
    • Smith, Kyle S;
    • Hadley, Jennifer;
    • Ermoian, Ralph;
    • MacDonald, Tobey J;
    • Goldman, Stewart;
    • Phillips, Peter;
    • Poussaint, Tina Young;
    • Olson, James M;
    • Ellison, David W;
    • Dunkel, Ira J;
    • Fouladi, Maryam;
    • Onar-Thomas, Arzu;
    • Northcott, Paul A
    Publication type:
    Article
    44

    A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 10, p. 1777, doi. 10.1093/neuonc/noab047
    By:
    • Fangusaro, Jason;
    • Onar-Thomas, Arzu;
    • Poussaint, Tina Young;
    • Wu, Shengjie;
    • Ligon, Azra H;
    • Lindeman, Neal;
    • Campagne, Olivia;
    • Banerjee, Anu;
    • Gururangan, Sridharan;
    • Kilburn, Lindsay B;
    • Goldman, Stewart;
    • Qaddoumi, Ibrahim;
    • Baxter, Patricia;
    • Vezina, Gilbert;
    • Bregman, Corey;
    • Patay, Zoltan;
    • Jones, Jeremy Y;
    • Stewart, Clinton F;
    • Fisher, Michael J;
    • Doyle, Laurence Austin
    Publication type:
    Article
    45

    Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1348, doi. 10.1093/neuonc/noab009
    By:
    • Katagi, Hiroaki;
    • Takata, Nozomu;
    • Aoi, Yuki;
    • Zhang, Yongzhan;
    • Rendleman, Emily J;
    • Blyth, Gavin T;
    • Eckerdt, Frank D;
    • Tomita, Yusuke;
    • Sasaki, Takahiro;
    • Saratsis, Amanda M;
    • Kondo, Akihide;
    • Goldman, Stewart;
    • Becher, Oren J;
    • Smith, Edwin;
    • Zou, Lihua;
    • Shilatifard, Ali;
    • Hashizume, Rintaro
    Publication type:
    Article
    46

    Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 12, p. 1862, doi. 10.1093/neuonc/noaa102
    By:
    • Dhall, Girish;
    • O'Neil, Sharon H;
    • Ji, Lingyun;
    • Haley, Kelley;
    • Whitaker, Ashley M;
    • Nelson, Marvin D;
    • Gilles, Floyd;
    • Gardner, Sharon L;
    • Allen, Jeffrey C;
    • Cornelius, Albert S;
    • Pradhan, Kamnesh;
    • Garvin, James H;
    • Olshefski, Randal S;
    • Hukin, Juliette;
    • Comito, Melanie;
    • Goldman, Stewart;
    • Atlas, Mark P;
    • Walter, Andrew W;
    • Sands, Stephen;
    • Sposto, Richard
    Publication type:
    Article
    47

    Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 11, p. 1696, doi. 10.1093/neuonc/noaa119
    By:
    • Goldman, Stewart;
    • Pollack, Ian F;
    • Jakacki, Regina I;
    • Billups, Catherine A;
    • Poussaint, Tina Y;
    • Adesina, Adekunle M;
    • Panigrahy, Ashok;
    • Parsons, Donald W;
    • Broniscer, Alberto;
    • Robinson, Giles W;
    • Robison, Nathan J;
    • Partap, Sonia;
    • Kilburn, Lindsay B;
    • Onar-Thomas, Arzu;
    • Dunkel, Ira J;
    • Fouladi, Maryam
    Publication type:
    Article
    48

    A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 10, p. 1527, doi. 10.1093/neuonc/noaa071
    By:
    • Ullrich, Nicole J;
    • Prabhu, Sanjay P;
    • Reddy, Alyssa T;
    • Fisher, Michael J;
    • Packer, Roger;
    • Goldman, Stewart;
    • Robison, Nathan J;
    • Gutmann, David H;
    • Viskochil, David H;
    • Allen, Jeffrey C;
    • Korf, Bruce;
    • Cantor, Alan;
    • Cutter, Gary;
    • Thomas, Coretta;
    • Perentesis, John P;
    • Mizuno, Tomoyuki;
    • Vinks, Alexander A;
    • Manley, Peter E;
    • Chi, Susan N;
    • Kieran, Mark W
    Publication type:
    Article
    49
    50